HWM
VCYT icon

HighMark Wealth Management’s Veracyte VCYT Stock Holding History

HighMark Wealth Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-750
Closed -$25.7K – 662
2025
Q3 		$25.7K Hold
750
– – 0.01% 211
2025
Q2 		$20.3K Hold
750
– – 0.01% 221
2025
Q1 		$22.2K Hold
750
– – 0.01% 192
2024
Q4 		$29.7K Hold
750
– – 0.02% 167
2024
Q3 		$25.5K Hold
750
– – 0.01% 184
2024
Q2 		$16.3K Hold
750
– – 0.01% 219
2024
Q1 		$16.6K Buy
+750
New +$18.3K 0.01% 214

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

HighMark Wealth Management's VCYT Position: Q4 2025 in Review

HighMark Wealth Management sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 750 shares — an estimated $25.7K sold.

HighMark Wealth Management first reported a position in VCYT in Q1 2024 and held it in 7 quarters. The position peaked at $29.7K in Q4 2024. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • HighMark Wealth Management reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
  • HighMark Wealth Management sold 750 Veracyte shares in Q4 2025, an estimated $25.7K.
  • HighMark Wealth Management first reported a position in Veracyte in Q1 2024 and held it in 7 quarters.
  • HighMark Wealth Management's Veracyte position peaked at $29.7K in Q4 2024.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on HighMark Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.